PORT ARTHUR, Texas (KPLC) - Extensive maintenance on the Rainbow Bridge in Southeast Texas is now finished, and the bridge is expected to open soon, authorities said. The maintenance began in March ...

A US appeals court has found in favor of Masimo in its fight against Apple over pulse oximetry patents, but in the court that matters, a ruling makes it clear that there won't be another ban on the ...

Irvine-based health technology and consumer electronics firm Masimo Corp. announced it entered into a definitive agreement to be acquired by healthcare company Danaher Corporation (Danaher). Under the ...

Danaher Corporation, a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation a leading specialty diagnostics provider ...

After a turbulent four years of restructuring and proxy battles that shook up its leadership, Masimo Corp. is set to be acquired by Danaher Corp. for $9.9 billion in yet another unexpected twist.

The firm initiated a new position by purchasing about 1.6 million shares. It position equals 15.3% of the fund’s 13F assets under management. Initiated a new position valued at about $203 million ...

Danaher, the NYSE-listed biotechnology and diagnostics company, is to acquire Masimo Corporation, the California-based firm best known for its development of optical pulse oximetry devices widely used ...

Danaher Corp. is snapping up patient monitoring medtech Masimo in a $9.9 billion deal aimed at strengthening its diagnostics portfolio. The acquisition values the device maker at $180 per share and ...

Danaher Corp. agreed to buy Masimo Corp., in a deal with an enterprise value of about $9.9 billion, allowing it to gain a foothold in the medical supply business. Danaher will pay $180 per share in ...

Danaher will acquire pulse oximeter maker Masimo in a $9.9 billion deal, as the life science firm looks to bulk up its diagnostics portfolio. The companies said on Tuesday that Danaher will pay $180 ...

Masimo stock jumped 34% after The Wall Street Journal reported that life-sciences conglomerate Danaher was nearing a $10 billion deal to buy the medical-device maker. Danaher shares were down over 6%.

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release fourth quarter and full year 2025 financial results for the period ended January 3, 2026, after the market closes on Thursday, ...